Background Some psychotropic medications have been associated with prolongation of the
QT interval and QT prolongation, especially in those with medical illness, and are linked to …

Objective: To report QT prolongation potential in selective serotonin reuptake inhibitors
(SSRIs) in order to advise clinicians on safe use of SSRIs other than citalopram in light of …

Background: Depression diagnosis requires five or more symptoms (Diagnostic and
Statistical Manual of Mental Disorders-DSM-5). One of them must be either Depressed mood …

Objective To quantify the impact of citalopram and other selective serotonin reuptake
inhibitors on corrected QT interval (QTc), a marker of risk for ventricular arrhythmia, in a large …

The Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood
Disorders, published a Japanese guideline for the treatment of late‐life depression in 2020 …

Objective To assess associations between different antidepressant treatments and rates of
three cardiovascular outcomes (myocardial infarction, stroke or transient ischaemic attack …

There is a definite correlation between cardiovascular diseases and depressive disorders.
Nevertheless, many aspects of this association have yet to be fully elucidated. Up to half of …

Introduction: Antidepressants (ADs) are widely used among elderly persons, making AD-
related safety an important issue. Areas covered: This review highlights safety …

Objective: To review QT prolongation potential with newer nonselective serotonin reuptake
inhibitor (non-SSRI) antidepressants. Data Sources: A PubMed literature search was …

Treatment with some types of antidepressants has been associated with sudden cardiac
death. It is unknown whether the increased risk is due to a class effect or related to specific …